Home › Funds › Franklin Resources › ABBV

Franklin Resources position in ABBV

ABBVIE INC · Health Care

Franklin Resources reported holding 19,697,133 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$5.81B, representing 1.33% of its reported portfolio and ranking #9 among its reported holdings. Franklin Resources has disclosed ABBV holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

Latest position (Q3 2026)19.70M sh
Reported value held$5.81B
Portfolio Weight1.33%
First reportedQ3 2021
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Franklin Resources's ABBV position evolved

Franklin Resources first disclosed a stake in ABBV in Q3 2021 at 16,567,208 shares (US$1.79B). The position peaked in Q3 2026 at 19,697,133 shares, worth US$5.81B. Across 21 filings, Franklin Resources increased the stake 9 time(s), trimmed it 11 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 19,697,133 shares valued at US$5.81B — a reduction of -228,099 shares quarter over quarter.. Notable position changes include a 47% increase in Q1 2024 (shares fell 5% over the following quarter), a 43% increase in Q2 2024 (shares rose 16% over the following quarter), a 37% increase in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2021 16.57M $1.79B New
Q4 2021 19.82M $2.68B Add
Q1 2022 14.17M $2.30B Reduce
Q2 2022 12.82M $1.96B Reduce
Q3 2022 11.82M $1.59B Reduce
Q4 2022 10.82M $1.75B Reduce
Q1 2023 8.08M $1.29B Reduce
Q2 2023 7.12M $959.44M Reduce
Q3 2023 7.23M $1.08B Add
Q4 2023 7.57M $1.17B Add
Q1 2024 11.15M $2.03B Add
Q2 2024 15.95M $2.74B Add
Q3 2024 13.87M $2.73B Reduce
Q4 2024 17.25M $3.06B Add
Q1 2025 17.67M $3.70B Add
Q2 2025 15.11M $2.80B Reduce
Q3 2025 14.55M $3.37B Reduce
Q4 2025 14.88M $3.40B Add
Q1 2026 14.55M $3.16B Reduce
Q2 2026 19.93M $5.01B Add
Q3 2026 19.70M $5.81B Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 30 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Franklin Resources held ABBV?

Franklin Resources has disclosed ABBV holdings in 21 of the last 21 reported quarters, going back to Q3 2021.

What is Franklin Resources's current position in ABBV?

As of Q3 2026, Franklin Resources holds 19.70M shares of ABBV (ABBVIE INC), valued at $5.81B, representing 1.33% of its reported portfolio and ranking #9.

Has Franklin Resources been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Franklin Resources reduced its position in ABBV. The position peaked in Q3 2026 at 19.70M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.